Dose-Finding Trial With Sugammadex Administered at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Participants of ASA Class 1-3 (P05944; MK-8616-024)
Clinical trial NCT00535743 · COMPLETED
Trial details
- NCT number
- NCT00535743
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-04
- Primary completion
- 2004-07-20
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.